6
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Cell-intrinsic adrenergic signaling controls the adaptive NK cell response to viral infection

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Natural killer (NK) cells are critical for protection against viruses. Diaz-Salazar et al. show that adrenergic neurons modulate the adaptive NK cell response in a cell-intrinsic manner. This study identifies the nervous system as a novel axis through which antigen-specific NK cell responses are regulated.

          Abstract

          Natural killer (NK) cells are innate lymphocytes that exhibit adaptive features, such as clonal expansion and memory, during viral infection. Although activating receptor engagement and proinflammatory cytokines are required to drive NK cell clonal expansion, additional stimulatory signals controlling their proliferation remain to be discovered. Here, we describe one such signal that is provided by the adrenergic nervous system, and demonstrate that cell-intrinsic adrenergic signaling is required for optimal adaptive NK cell responses. Early during mouse cytomegalovirus (MCMV) infection, NK cells up-regulated Adrb2 (which encodes the β2-adrenergic receptor), a process dependent on IL-12 and STAT4 signaling. NK cell–specific deletion of Adrb2 resulted in impaired NK cell expansion and memory during MCMV challenge, in part due to a diminished proliferative capacity. As a result, NK cell-intrinsic adrenergic signaling was required for protection against MCMV. Taken together, we propose a novel role for the adrenergic nervous system in regulating circulating lymphocyte responses to viral infection.

          Related collections

          Most cited references34

          • Record: found
          • Abstract: found
          • Article: not found

          Up on the tightrope: natural killer cell activation and inhibition.

          Natural killer (NK) cells circulate through the blood, lymphatics and tissues, on patrol for the presence of transformed or pathogen-infected cells. As almost all NK cell receptors bind to host-encoded ligands, signals are constantly being transmitted into NK cells, whether they interact with normal or abnormal cells. The sophisticated repertoire of activating and inhibitory receptors that has evolved to regulate NK cell activity ensures that NK cells protect hosts against pathogens, yet prevents deleterious NK cell-driven autoimmune responses. Here I highlight recent advances in our understanding of the structural properties and signaling pathways of the inhibitory and activating NK cell receptors, with a particular focus on the ITAM-dependent activating receptors, the NKG2D-DAP10 receptor complexes and the CD244 receptor system.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            The neuropeptide NMU amplifies ILC2-driven allergic lung inflammation

            Neuromedin receptor NMUR1 is specifically expressed by a subpopulation of type 2 innate lymphoid cells and promotes the inflammatory response of these cells in response to allergens, indicating the importance of neuro-immune crosstalk in allergic responses.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Neuronal regulation of type 2 innate lymphoid cells via neuromedin U

              Group 2 innate lymphoid cells (ILC2s) regulate inflammation, tissue repair and metabolic homeostasis1. ILC2 activation is driven by host-derived cytokines and alarmins1. While discrete immune cell subsets integrate nervous system cues2–4, it remains unclear whether neuronal-derived signals control ILC2s. Here we show that Neuromedin U (NMU) is a uniquely fast and potent regulator of type 2 innate immunity in the context of a novel neuron-ILC2 unit. We found that ILC2s selectively express Neuromedin U receptor 1 (Nmur1), while mucosal neurons express NMU. ILC2-autonomous activation with NMU resulted in immediate and strong production of innate inflammatory and tissue repair cytokines, in a NMUR1-dependent manner. NMU controlled ILC2s downstream of extracellular signal–regulated kinase (ERK) and calcium (Ca2+)-influx-dependent activation of Calcineurin and nuclear factor of activated T cells (NFAT). NMU treatment in vivo resulted in immediate protective type 2 responses. Accordingly, ILC2-autonomous ablation of Nmur1 led to impaired type 2 responses and poor worm infection control. Strikingly, mucosal neurons were found adjacent to ILC2s, directly sensed worm products and alarmins to induce NMU and to control innate type 2 cytokines. Our work reveals that neuron-ILC2 cell units are poised to confer a first-line of immediate tissue protection via coordinated neuro-immune sensory responses.
                Bookmark

                Author and article information

                Contributors
                Role: ConceptualizationRole: Data curationRole: Formal analysisRole: InvestigationRole: MethodologyRole: Project administrationRole: SupervisionRole: ValidationRole: VisualizationRole: Writing – original draftRole: Writing – review & editing
                Role: ConceptualizationRole: Formal analysisRole: InvestigationRole: ValidationRole: VisualizationRole: Writing – review & editing
                Role: InvestigationRole: MethodologyRole: ResourcesRole: Writing – review & editing
                Role: Data curationRole: Formal analysisRole: VisualizationRole: Writing – review & editing
                Role: Data curationRole: Formal analysisRole: Software
                Role: Data curationRole: Formal analysisRole: InvestigationRole: MethodologyRole: Visualization
                Role: ConceptualizationRole: Data curationRole: Formal analysisRole: Funding acquisitionRole: InvestigationRole: MethodologyRole: Project administrationRole: ResourcesRole: SoftwareRole: SupervisionRole: ValidationRole: VisualizationRole: Writing – original draftRole: Writing – review & editing
                Journal
                J Exp Med
                J. Exp. Med
                jem
                The Journal of Experimental Medicine
                Rockefeller University Press
                0022-1007
                1540-9538
                6 April 2020
                11 February 2020
                : 217
                : 4
                : e20190549
                Affiliations
                [1 ]Immunology Program, Memorial Sloan Kettering Cancer Center, New York, NY
                [2 ]Department of Immunology and Microbial Pathogenesis, Weill Cornell Medical College, New York, NY
                [3 ]Division of Animal Physiology and Immunology, Technical University of Munich, Freising, Germany
                [4 ]Louis V. Gerstner, Jr. Graduate School of Biomedical Sciences, Memorial Sloan Kettering Cancer Center, New York, NY
                Author notes
                Correspondence to Joseph C. Sun: sunj@ 123456mskcc.org

                Disclosures: The authors declare no competing interests exist.

                Author information
                https://orcid.org/0000-0001-9735-2253
                https://orcid.org/0000-0001-8037-0076
                https://orcid.org/0000-0001-8062-9033
                Article
                jem.20190549
                10.1084/jem.20190549
                7144534
                32045471
                9395ac6b-5765-43de-9285-a292740d01e6
                © 2020 Diaz-Salazar et al.

                This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication date (see http://www.rupress.org/terms/). After six months it is available under a Creative Commons License (Attribution–Noncommercial–Share Alike 4.0 International license, as described at https://creativecommons.org/licenses/by-nc-sa/4.0/).

                History
                : 26 March 2019
                : 23 October 2019
                : 13 January 2020
                Page count
                Pages: 11
                Funding
                Funded by: Commission for Cultural, Educational and Scientific Exchange
                Funded by: "la Caixa" Foundation, DOI http://dx.doi.org/10.13039/100010434;
                Award ID: LCF/BQ/AA17/11610016
                Funded by: National Institutes of Health, DOI http://dx.doi.org/10.13039/100000002;
                Award ID: CA009149
                Funded by: Cancer Research Institute, DOI http://dx.doi.org/10.13039/100000884;
                Funded by: Cancer Research Institute, DOI http://dx.doi.org/10.13039/100000884;
                Funded by: Ludwig Center for Cancer Immunotherapy
                Funded by: American Cancer Society, DOI http://dx.doi.org/10.13039/100000048;
                Funded by: Burroughs Wellcome Fund, DOI http://dx.doi.org/10.13039/100000861;
                Funded by: National Institutes of Health, DOI http://dx.doi.org/10.13039/100000002;
                Award ID: AI100874
                Award ID: AI130043
                Award ID: P30CA008748
                Categories
                Brief Definitive Report
                Infectious Disease and Host Defense
                Neuroinflammation

                Medicine
                Medicine

                Comments

                Comment on this article